Search
for
Sort by
Research 511–540 of 1000+
- Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
- Enhancing the Growth of Natural Eyelashes: The Mechanism of Bimatoprost-Induced Eyelash Growth
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- Treatments for alopecia areata: a network meta-analysis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Trends and techniques: a statistical review of hair care product evaluation research
- A hair growth questionnaire for use in the evaluation of therapeutic effects in men
- Androgens in women
- A Brief Review on Acne Vulgaris: Chronic Inflammatory Disease
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
- Randomized Control Clinical Trial to assess the combine effect of Bhringaraja Taila Shiroabhyanga and Yastimadhuka Taila Nasya in Khalitya of Females
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials
- Biomarker-based methods for determining noncompliance in a prevention trial
- A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
- Scalp acupoint catgut embedding combined with topical 5% minoxidil tincture to improve male androgenetic alopecia: protocol for a randomised controlled trial
- Racial and Ethnic Disparities in Androgenetic Alopecia Clinical Trials in the United States
- Effects of supplementation with two probiotic strains (Lactobacillus helveticus and Bifidobacterium longum) on hormonal status, oxidative stress, and clinical symptoms in women with polycystic ovary syndrome: a randomized clinical trial
- Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial.
- Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial
- A Split Scalp Study of Single versus Double Spin Platelet-rich plasma Injections in Treatment of Female Pattern Hair Loss: Clinical Effect and Relation to Vascular Endothelial Growth Factor in PRP
- LB1159 First-in-human clinical trial evaluating AI-09, a novel long-lasting ready-to-use liquid injectable neuromodulator for the treatment of glabellar lines
- Comparing the Efficacy of Mesotherapy to Topical Minoxidil in the Treatment of Female Pattern Hair Loss Using Ultrasound Biomicroscopy: A Randomized Controlled Trial.
- 34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials